Mergers & Acquisitions

• Hyperfine, Inc.'s (Nasdaq: HYPR) business combination, valued at $580 million, with Liminal Sciences and the SPAC, HealthCor Catalio Acquisition Corp.
• The Metals Company’s (Nasdaq: TMC) (formerly DeepGreen Metals) business combination, valued at $2.9 billion, with the SPAC, Sustainable Opportunities Acquisition Corporation
• Azenta Life Sciences' (Nasdaq: AZTA) (formerly Brooks Automation, Inc.) $3 billion sale of its Semiconductor Solutions business to private equity firm Thomas H. Lee Partners, L.P.
• Optum’s acquisition of Atrius Health
• Quantum-SI’s (Nasdaq: QSI) $1.46 billion business combination with the SPAC, HighCape Capital Acquisition Corp.
• Butterfly Network’s (NYSE: BFLY) $1.5 billion business combination with the SPAC, Longview Acquisition Corp.
• QIAGEN in its proposed $12.5 billion sale to Thermo Fisher Scientific
• Brooks Automation’s approximately $450 million purchase of genomics service provider Genewiz Group
• Brooks Automation’s $675 million sale of its semiconductor cryogenics business to Edwards Vacuum LLC (a member of the Atlas Copco Group)
• John Hancock Financial Network’s sale of Signator Investors to Advisor Group
• Connance’s sale to Waystar Health
• Optum’s purchase of Reliant Medical Group
• Fidelity’s purchase of a software solutions company
• C&S Wholesale Grocers’ purchase of the assets of Davidson Co., Inc.
• Brooks Automation’s $127 million purchase of BioStorage Technologies
• John Hancock Financial Network’s purchase of the assets of Transamerica Financial Advisors
• Naurex’s sale to Allergan
• Leerink Swann’s sale of the assets of Leerink Swann Consulting to NCI Healthcare
• John Hancock Financial Network’s purchase of Symetra Investment Services
• C&S Wholesale Grocers’ purchase of the assets of Associated Wholesalers
• Humedica’s sale to UnitedHealth Group
• Piramal Healthcare Limited’s $635 million purchase of Decision Resources Group
• iMDsoft’s $60 million sale to TPG
• Ion Torrent Systems’ $725 million sale to Life Technologies
• Amicas’ $267 million sale to Merge Healthcare
• Vertex Pharmaceuticals’ $400 million purchase of ViroChem Pharma
• iBasis’ $100 million sale to Royal KPN
• Qiagen’s $1.6 billion purchase of Digene Corporation

Public Offerings

• Vertex Pharmaceuticals in over $2.5 billion in equity and debt offerings

Michael also serves as counsel to Brooks Automation and John Hancock Life Insurance Company. Private company clients include C&S Wholesale Grocers, LAM Therapeutics and W.E. Aubuchon Co.